Alan Reider has 35 years of experience representing national healthcare corporations, pharmaceutical and medical device companies, as well as institutional providers and individual practitioners and suppliers. His practice focuses on regulatory compliance, fraud and abuse counseling, reimbursement, coverage and certification issues, and on relationships with third-party payors. Mr. Reider has defended providers and practitioners in Anti-Kickback, Stark law, False Claims Act, Civil Money Penalty, and suspension and exclusion actions. He has extensive experience performing regulatory due diligence in connection with potential acquisition targets, developing compliance programs, and negotiating Corporate Integrity Agreements. He frequently appears before federal agencies, including Centers for Medicare and Medicaid Services, Office of Inspector General, United States Department of Justice, and state attorneys general offices throughout the country.
From 1975 – 1980, Mr. Reider was with the Health Care Financing Administration (now known as the Centers for Medicare and Medicaid Services) of the United States Department of Health & Human Services.
Mr. Reider frequently lectures at healthcare meetings throughout the country, particularly relating to fraud and abuse and compliance related topics. He has also published several book chapters and is a frequent contributor to health industry periodicals.
- National Medical Care as lead defense counsel in the government investigation—at the time, the largest healthcare fraud case in history.
- National Health Laboratories as lead defense attorney in the landmark settlement, the first major healthcare False Claims Act case.
- Space Coast Cancer Center in connection with a False Claims Act case, in which the Federal District Court granted our Motion to Dismiss.
- Midwest Hospital in connection with a reverse False Claims Act case, obtaining the government's agreement not to intervene.
- Physician professional society in the development of a model compliance plan documents.
- Multiple physician practices in transactions with physician practice management and integrated services entities.
- Medical device and pharmaceutical companies in obtaining Medicare coverage for off-label uses.
Healthcare: Regulatory and Litigation (Nationwide) (2016-2017)
- JD, Boston University School of Law, 1975
- MPH, University of Texas School of Public Health, 1972
- AB, Brown University, 1971
- District of Columbia
- Chief, Review Policy Branch, Office of Professional Standards Review Organizations, Health Care Financing Administration, US Department of Health & Human Services
Member, American Health Lawyers Association